Searched for
LUPIN USFDA APPROVAL
Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...- Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepinessLupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain...
- Stocks in news: Airtel, Paytm, SpiceJet, ONGC and ZEEMarkets extended their losing streak for a fifth consecutive session on Monday. Airtel Payments Bank appointed Shabnam Sinha as its new cha...
- Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessPharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treatin...
- Lupin launches generic Sugammadex injection in USLupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Admini...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- Lupin rallies 4% after multiple approvals from USFDAIn a regulatory filing, the company said it has received approval from the USFDA for mirabegron extended-release tablets.
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.
- USFDA classifies Lupin's Somerset facility as 'Official Action Indicated''Official Action Indicated', means approvals of pending applications or supplements from this site maybe withheld.
- Lupin gets USFDA nod for Diclofenac capsules' generic versionLupin has 139 product filings pending approval with the USFDA. Cumulative filings with the USFDA now stand at 341 with the company having r...
- Lupin gets USFDA nod for generic pain relieving drugAs per IMS MAT sales data, Hydrocodone Bitartrate and Acetaminophen tablets had sales of USD 89.6 million in the US market.
- Lupin gets USFDA nod to market oral contraceptivesLupin has received final approval from the US health regulator to market generic version of Warner Chilcott's oral contraceptive Generess F...
- Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
- Lupin launches HIV drug in the US with marketing exclusivityLupin launched the generic version of ViiV Healthcare's Trizivir tablets in the US market with 180-days of marketing exclusivity.
- Lupin gets USFDA nod to market HIV drug in the US marketThe company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.
- Lupin gets USFDA approval for arthritis tabletsLupin Pharmaceuticals Inc has been granted final approval by US Food and Drug Administration for Nabumetone tablets in strengths of 500mg a...
- Sharekhan puts buy on LupinSharekhan has come out with a ‘buy’ on Lupin on account of its differentiated business model with global dominance in certain products, foc...
- Lupin gets USFDA nod for TrandolaprilLupin Ltd on Thursday said it has received US Food and Drug Administration (USFDA) approval for multiple strengths of Trandolapril Tablets ...
- Lupin gets US nod for CefdinirLupin Ltd on Friday said it has received the approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Cefdinir Suspensio...
Load More
